Global Artificial Pancreas Devices Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024


Report ID : RNR-264981 Category : Pharma Healthcare Published Date : Mar-2019
Publisher : GlobalInfo Research Pages : 119 Format : PDF

Avail 15% Discount, Use RNR15 Coupon Code.
T&C*

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a 'closed-loop' system, an 'automated insulin delivery' system, or an 'autonomous system for glycemic control.'
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.

SCOPE OF THE REPORT:

The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.

The worldwide market for Artificial Pancreas Devices Systems is expected to grow at a CAGR of roughly 13.8% over the next five years, will reach 120 million US$ in 2024, from 56 million US$ in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Artificial Pancreas Devices Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Market Segment by Applications, can be divided into
Hospitals
Clinics
1 MARKET OVERVIEW

1.1 Artificial Pancreas Devices Systems Introduction
1.2 Market Analysis by Type
  1.2.1 Threshold Suspended Device Systems
  1.2.2 Hybrid Closed-loop APDS
  1.2.3 Other Systems
1.3 Market Analysis by Applications
  1.3.1 Hospitals
  1.3.2 Clinics
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2014-2024)
    1.4.1.2 Canada Market States and Outlook (2014-2024)
    1.4.1.3 Mexico Market States and Outlook (2014-2024)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2014-2024)
    1.4.2.2 France Market States and Outlook (2014-2024)
    1.4.2.3 UK Market States and Outlook (2014-2024)
    1.4.2.4 Russia Market States and Outlook (2014-2024)
    1.4.2.5 Italy Market States and Outlook (2014-2024)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2014-2024)
    1.4.3.2 Japan Market States and Outlook (2014-2024)
    1.4.3.3 Korea Market States and Outlook (2014-2024)
    1.4.3.4 India Market States and Outlook (2014-2024)
    1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2014-2024)
    1.4.4.2 Egypt Market States and Outlook (2014-2024)
    1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    1.4.4.4 South Africa Market States and Outlook (2014-2024)
    1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Medtronic
  2.1.1 Business Overview
  2.1.2 Artificial Pancreas Devices Systems Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bigfoot Biomedical
  2.2.1 Business Overview
  2.2.2 Artificial Pancreas Devices Systems Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Beta Bionics
  2.3.1 Business Overview
  2.3.2 Artificial Pancreas Devices Systems Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Admetsys
  2.4.1 Business Overview
  2.4.2 Artificial Pancreas Devices Systems Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Insulet
  2.5.1 Business Overview
  2.5.2 Artificial Pancreas Devices Systems Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Insulet Artificial Pancreas Devices Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Tandem Diabetes Care
  2.6.1 Business Overview
  2.6.2 Artificial Pancreas Devices Systems Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Defymed
  2.7.1 Business Overview
  2.7.2 Artificial Pancreas Devices Systems Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Defymed Artificial Pancreas Devices Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2017-2018)

3.1 Global Artificial Pancreas Devices Systems Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
  3.3.1 Top 3 Artificial Pancreas Devices Systems Manufacturer Market Share in 2018
  3.3.2 Top 6 Artificial Pancreas Devices Systems Manufacturer Market Share in 2018
3.4 Market Competition Trend

4 GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET ANALYSIS BY REGIONS

4.1 Global Artificial Pancreas Devices Systems Sales, Revenue and Market Share by Regions
  4.1.1 Global Artificial Pancreas Devices Systems Sales and Market Share by Regions (2014-2019)
  4.1.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Regions (2014-2019)
4.2 North America Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
4.3 Europe Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
4.5 South America Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)

5 NORTH AMERICA ARTIFICIAL PANCREAS DEVICES SYSTEMS BY COUNTRY

5.1 North America Artificial Pancreas Devices Systems Sales, Revenue and Market Share by Country
  5.1.1 North America Artificial Pancreas Devices Systems Sales and Market Share by Country (2014-2019)
  5.1.2 North America Artificial Pancreas Devices Systems Revenue and Market Share by Country (2014-2019)
5.2 United States Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
5.3 Canada Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
5.4 Mexico Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)

6 EUROPE ARTIFICIAL PANCREAS DEVICES SYSTEMS BY COUNTRY

6.1 Europe Artificial Pancreas Devices Systems Sales, Revenue and Market Share by Country
  6.1.1 Europe Artificial Pancreas Devices Systems Sales and Market Share by Country (2014-2019)
  6.1.2 Europe Artificial Pancreas Devices Systems Revenue and Market Share by Country (2014-2019)
6.2 Germany Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
6.3 UK Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
6.4 France Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
6.5 Russia Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
6.6 Italy Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)

7 ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICES SYSTEMS BY COUNTRY

7.1 Asia-Pacific Artificial Pancreas Devices Systems Sales, Revenue and Market Share by Country
  7.1.1 Asia-Pacific Artificial Pancreas Devices Systems Sales and Market Share by Country (2014-2019)
  7.1.2 Asia-Pacific Artificial Pancreas Devices Systems Revenue and Market Share by Country (2014-2019)
7.2 China Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
7.3 Japan Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
7.4 Korea Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
7.5 India Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)

8 SOUTH AMERICA ARTIFICIAL PANCREAS DEVICES SYSTEMS BY COUNTRY

8.1 South America Artificial Pancreas Devices Systems Sales, Revenue and Market Share by Country
  8.1.1 South America Artificial Pancreas Devices Systems Sales and Market Share by Country (2014-2019)
  8.1.2 South America Artificial Pancreas Devices Systems Revenue and Market Share by Country (2014-2019)
8.2 Brazil Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
8.3 Argentina Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
8.4 Colombia Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)

9 MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICES SYSTEMS BY COUNTRIES

9.1 Middle East and Africa Artificial Pancreas Devices Systems Sales, Revenue and Market Share by Country
  9.1.1 Middle East and Africa Artificial Pancreas Devices Systems Sales and Market Share by Country (2014-2019)
  9.1.2 Middle East and Africa Artificial Pancreas Devices Systems Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
9.3 Turkey Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
9.4 Egypt Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
9.5 Nigeria Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)
9.6 South Africa Artificial Pancreas Devices Systems Sales and Growth Rate (2014-2019)

10 GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET SEGMENT BY TYPE

10.1 Global Artificial Pancreas Devices Systems Sales, Revenue and Market Share by Type (2014-2019)
  10.1.1 Global Artificial Pancreas Devices Systems Sales and Market Share by Type (2014-2019)
  10.1.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Type (2014-2019)
10.2 Threshold Suspended Device Systems Sales Growth and Price
  10.2.1 Global Threshold Suspended Device Systems Sales Growth (2014-2019)
  10.2.2 Global Threshold Suspended Device Systems Price (2014-2019)
10.3 Hybrid Closed-loop APDS Sales Growth and Price
  10.3.1 Global Hybrid Closed-loop APDS Sales Growth (2014-2019)
  10.3.2 Global Hybrid Closed-loop APDS Price (2014-2019)
10.4 Other Systems Sales Growth and Price
  10.4.1 Global Other Systems Sales Growth (2014-2019)
  10.4.2 Global Other Systems Price (2014-2019)

11 GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET SEGMENT BY APPLICATION

11.1 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)

12 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FORECAST (2019-2024)

12.1 Global Artificial Pancreas Devices Systems Sales, Revenue and Growth Rate (2019-2024)
12.2 Artificial Pancreas Devices Systems Market Forecast by Regions (2019-2024)
  12.2.1 North America Artificial Pancreas Devices Systems Market Forecast (2019-2024)
  12.2.2 Europe Artificial Pancreas Devices Systems Market Forecast (2019-2024)
  12.2.3 Asia-Pacific Artificial Pancreas Devices Systems Market Forecast (2019-2024)
  12.2.4 South America Artificial Pancreas Devices Systems Market Forecast (2019-2024)
  12.2.5 Middle East and Africa Artificial Pancreas Devices Systems Market Forecast (2019-2024)
12.3 Artificial Pancreas Devices Systems Market Forecast by Type (2019-2024)
  12.3.1 Global Artificial Pancreas Devices Systems Sales Forecast by Type (2019-2024)
  12.3.2 Global Artificial Pancreas Devices Systems Market Share Forecast by Type (2019-2024)
12.4 Artificial Pancreas Devices Systems Market Forecast by Application (2019-2024)
  12.4.1 Global Artificial Pancreas Devices Systems Sales Forecast by Application (2019-2024)
  12.4.2 Global Artificial Pancreas Devices Systems Market Share Forecast by Application (2019-2024)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source